ServiceSource Appoints Jennifer Frank as Chief Accounting Officer

ServiceSource Appoints Jennifer Frank as Chief Accounting Officer

 

DENVER–(BUSINESS WIRE)–ServiceSource International, Inc. (NASDAQ: SREV), the customer journey experience company, announces the promotion of Jenny Frank to the position of Chief Accounting Officer. Reporting to Chief Financial Officer Chad Lyne, Ms. Frank will directly oversee all corporate accounting, SEC reporting, treasury, procurement, stock administration, and internal audit functions globally.

“During her three years at ServiceSource, Jenny has made significant contributions to the company and has been instrumental in recruiting and building a world-class team,” said Chad W. Lyne, chief financial officer, ServiceSource. “We look forward to her ongoing leadership in this expanded role and the positive impact her accounting, finance, and audit expertise will have on our long-term strategic priorities.”

Ms. Frank is a seasoned leader with more than a decade of public accounting and audit experience. Prior to her most recent role at ServiceSource as Vice President and Corporate Controller, Ms. Frank spent more than four years managing corporate accounting, SEC reporting, stock administration, and accounts payable functions for a publicly-traded industrial real estate investment company. A Certified Public Accountant, Ms. Frank also spent six years in public accounting, serving on and managing audit engagements for high-tech, pharmaceutical, construction, and manufacturing companies.

Ms. Frank graduated from the University of Northern Colorado with a Bachelor of Science in Business Administration with an emphasis in Accounting.

About ServiceSource

ServiceSource International, Inc. (NASDAQ: SREV) is a global outsourced go-to-market services provider that accelerates B2B digital sales and customer success transformation. Our expert sales professionals, data-powered insights and proven methodologies scale and reimagine customer journey experiences (CJX™) into profitable business outcomes. Backed by more than 20 years of experience, ServiceSource drives billions of dollars in client value annually, conducting commerce in 45 languages and 178 countries. To learn more about how we design, develop and manage CJX solutions that transform the agility, speed, efficiency and value of our clients’ growth initiatives, visit www.servicesource.com.

Connect with ServiceSource:

ServiceSource

LinkedIn

Twitter

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding our ability to enable our clients to execute on our longer-term strategic priorities. These forward-looking statements are based on our current assumptions and beliefs, and involve risks and uncertainties that could cause our results to differ materially from our forward-looking statements. Those risks and uncertainties include that we may be unable to attract and retain the highly skilled employees we need to support our planned growth; changes in market conditions that impact our ability to sell our solutions and/or generate service revenue on our clients’ behalf; general political, economic and market conditions and events; and other risks and uncertainties described more fully in our periodic reports and registration statements filed with the Securities and Exchange Commission, which can be obtained online at the Commission’s website at https://www.sec.gov. All forward-looking statements in this press release are based on information currently available to us, and we assume no obligation to update these forward-looking statements.

Trademarks

ServiceSource®, and any ServiceSource product or service names or logos above are trademarks of ServiceSource International, Inc. All other trademarks used herein belong to their respective owners.

Media and Investor Contact:

Elise Brassell

[email protected]

[email protected]

303-889-8616

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS: Software Technology Hardware Data Management

MEDIA:

Logo
Logo

QAD Declares Quarterly Cash Dividend of $0.072 Per Class A Share and $0.06 Per Class B Share

QAD Declares Quarterly Cash Dividend of $0.072 Per Class A Share and $0.06 Per Class B Share

SANTA BARBARA, Calif.–(BUSINESS WIRE)–
QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB), a leading provider of enterprise business software and services for global manufacturers, today announced that its Board of Directors has declared a quarterly cash dividend of $0.072 per share of Class A common stock and $0.06 per share of Class B common stock payable on January 7, 2021 to shareholders of record at the close of business on December 29, 2020.

Continuing quarterly dividends are subject to the approval of QAD’s Board of Directors whose decision will consider factors such as the continued profitability and liquidity requirements of the company.

About QAD – Enabling the Adaptive Manufacturing Enterprise

QAD Inc. is a leading provider of adaptive, cloud-based enterprise software and services for global manufacturing companies. Global manufacturers face ever-increasing disruption caused by technology-driven innovation and changing consumer preferences. In order to survive and thrive, manufacturers must be able to innovate and change business models at unprecedented rates of speed. QAD calls these companies Adaptive Manufacturing Enterprises. QAD solutions help customers in the automotive, life sciences, consumer products, food and beverage, high tech and industrial manufacturing industries rapidly adapt to change and innovate for competitive advantage.

Founded in 1979 and headquartered in Santa Barbara, California, QAD has 29 offices globally. Over 2,000 manufacturing companies have deployed QAD solutions including enterprise resource planning (ERP), demand and supply chain planning (DSCP), global trade and transportation execution (GTTE) and quality management system (QMS) to become an Adaptive Manufacturing Enterprise. To learn more, visit www.qad.com or call +1 805-566-6100. Find us on Twitter, LinkedIn, Facebook, Instagram and Pinterest.

“QAD” is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.

Note to Investors: This press release contains certain forward-looking statements made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding projections of revenue, income and loss, capital expenditures, plans and objectives of management regarding the company’s business, future economic performance or any of the assumptions underlying or relating to any of the foregoing. Forward-looking statements are based on the company’s current expectations. Words such as “expects,” “believes,” “anticipates,” “could,” “will likely result,” “estimates,” “intends,” “may,” “projects,” “should,” “would,” “might,” “plan” and variations of these words and similar expressions are intended to identify these forward-looking statements. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to: risks associated with the COVID-19 (novel coronavirus) pandemic or other catastrophic events that may harm our business; adverse economic, market or geo-political conditions that may disrupt our business; our cloud service offerings, such as defects and disruptions in our services, our ability to properly manage our cloud service offerings, our reliance on third-party hosting and other service providers, and our exposure to liability and loss from security breaches; demand for the company’s products, including cloud service, licenses, services and maintenance; pressure to make concessions on our pricing and changes in our pricing models; protection of our intellectual property; dependence on third-party suppliers and other third-party relationships, such as sales, services and marketing channels; changes in our revenue, earnings, operating expenses and margins; the reliability of our financial forecasts and estimates of the costs and benefits of transactions; the ability to leverage changes in technology; defects in our software products and services; third-party opinions about the company; competition in our industry; the ability to recruit and retain key personnel; delays in sales; timely and effective integration of newly acquired businesses; economic conditions in our vertical markets and worldwide; exchange rate fluctuations; and the global political environment. For a more detailed description of the risk factors associated with the company and factors that may affect our forward-looking statements, please refer to the company’s latest Annual Report on Form 10-K and, in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. Management does not undertake to update these forward-looking statements except as required by law.

Kara Bellamy

Chief Accounting Officer

805.566.6100

[email protected]

Laurie Berman

PondelWilkinson Inc.

310.279.5980

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Technology Other Manufacturing Manufacturing

MEDIA:

Logo
Logo

Zoned Properties Announces Market Launch of The Open Dør Cannabis Retail Franchise

Zoned Properties Announces Market Launch of The Open Dør Cannabis Retail Franchise

Zoned Properties provided the start-up capital and will serve as a strategic partner for the dispensary retail franchisor

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–
Zoned Properties®, Inc. (OTCQB: ZDPY), a strategic real estate development firm whose primary mission is to provide real estate and sustainability services for the regulated cannabis industry, positioning the company for property acquisitions and revenue growth, today announced the market launch of its partnership with dispensary retail franchisor, The Open Dør.

Earlier this year, Zoned Properties invested the start-up capital for the cannabis franchise organization and has provided leadership guidance to The Open Dør founders. As a strategic partner, Zoned Properties intends to play a significant role related to the intricacies of capital investment and commercial real estate development in the regulated cannabis industry.

Co-founded by international franchisor Kathryn Blackwell and cannabis compliance expert Chelsea Mulligan, The Open Dør concept was designed to remove the complexities from cannabis and help license holders enter the market faster and with more efficiency. Blackwell will serve as CEO and Mulligan will serve as COO at The Open Dør.

“After years of professional interactions and collaboration with Kathryn and Chelsea, we made the decision to back this exciting new venture that we believe the regulated cannabis market desperately needs in its evolution as an emerging industry,” stated Bryan McLaren, CEO of Zoned Properties.

Pioneered by proven business professionals and led by strong female visionaries, The Open Dør provides a modern cannabis retail model with a turnkey approach. Through Zoned Properties, McLaren will serve as Strategic Real Estate Advisor at The Open Dør, providing an extra layer of start-up support.

“The Open Dør gives cannabis stakeholders and dispensary license holders the opportunity to invest in a franchise brand built on proven and compliant operations with an elevated consumer retail experience,” said The Open Dør co-founders in a joint statement.

Headquartered in Scottsdale, Arizona, cannabis franchise opportunities with The Open Dør are available in states throughout the U.S. with legal medical and adult-use marijuana programs.

“We believe The Open Dør will become one of the most important, value-driven catalysts for Zoned Properties to expand its business model and grow to meet the needs of our industry. The Open Dør team and its consumer-focused culture represents a bright future for the cannabis community,” commented McLaren. “We intend to provide on-going support for the expansion of The Open Dør, positioning Zoned Properties to directly benefit from both the organizational partnership and future equity rights related to the convertible start-up capital we provided.”

About Zoned Properties, Inc. (OTCQB: ZDPY):

Zoned Properties is a strategic real estate development firm whose primary mission is to provide real estate and sustainability services for clients in the regulated cannabis industry, positioning the company for real estate acquisitions and revenue growth. We intend to pioneer sustainable development for emerging industries, including the regulated cannabis industry. We are an accredited member of the Better Business Bureau, the U.S. Green Building Council, and the Forbes Real Estate Council. We focus on investing capital to acquire and develop commercial properties to be leased on a triple-net basis, and engaging clients that face zoning, permitting, development, and operational challenges. We provide development strategies and advisory services that could potentially have a major impact on cash flow and property value. We do not grow, harvest, sell or distribute cannabis or any substances regulated under United States law such as the Controlled Substance Act of 1970, as amended (the “CSA”).

Website: www.ZonedProperties.com

Twitter: @ZonedProperties

LinkedIN: @ZonedProperties

About The Open Dør:

Established in 2020, The Open Dør is a national cannabis retail franchise offering license holders and industry stakeholders the opportunity to invest in a turnkey dispensary model in legal medical marijuana and adult-use markets. Headquartered in Scottsdale, Arizona, The Open Dør leadership team includes co-founder and CEO Kathryn Blackwell, co-founder and COO Chelsea Mulligan, and Strategic Real Estate Advisor Bryan McLaren.

Designed to remove the complexities from dispensary operations, The Open Dør cannabis franchise opportunity includes license to brand name, access to architectural dispensary drawings, product contracts and negotiations, operational procedures and support, staff training and educational modules, real estate and zoning guidance, corporate social responsibility assimilation, as well as ongoing support.

For more information visit www.TheOpenDor.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

COVID-19 Statement

In March 2020, the World Health Organization declared COVID-19 a global pandemic and recommended containment and mitigation measures worldwide. We are monitoring this closely, and although operations have not been materially affected by the COVID-19 outbreak to date, the ultimate duration and severity of the outbreak and its impact on the economic environment and our business is uncertain. Currently, all of the properties in our portfolio are open to our Significant Tenants and their customers and will remain open pursuant to state and local government requirements. At this time, we do not foresee any material changes to our operations from COVID-19. Our tenants are continuing to generate revenue at these properties and they have continued to make rental payments in full and on time and we believe the tenants’ liquidity position is sufficient to cover its expected rental obligations. Accordingly, while we do not anticipate an impact on our operations, we cannot estimate the duration of the pandemic and potential impact on our business if the properties must close or if the tenants are otherwise unable or unwilling to make rental payments. In addition, a severe or prolonged economic downturn could result in a variety of risks to our business, including weakened demand for our properties and a decreased ability to raise additional capital when needed on acceptable terms, if at all. At this time, the Company is unable to estimate the impact of this event on its operations.

Media Relations

Proven Media

Neko Catanzaro

Tel (401) 484-4980

[email protected]

Investor Relations

Zoned Properties, Inc.

Bryan McLaren

Tel (877) 360-8839

[email protected]

www.zonedproperties.com

KEYWORDS: Arizona United States North America

INDUSTRY KEYWORDS: Alternative Medicine Retail Health Tobacco Commercial Building & Real Estate Construction & Property

MEDIA:

Logo
Logo

PURE Bioscience Reports Fiscal First Quarter 2021 Financial Results

PURE Bioscience Reports Fiscal First Quarter 2021 Financial Results

Update on Business Segments and PURE’s SDC-Based Antimicrobial Food Safety Solutions

RANCHO CUCAMONGA, Calif.–(BUSINESS WIRE)–
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2020.

Summary of Results – Fiscal First Quarter Operations

  • Net product sales for the fiscal first quarter ended October 31, 2020 increased 256% to 1,417,000, compared to $398,000 for the fiscal first quarter ended October 31, 2019. The increase of $1,019,000 was attributable to increased sales across our distribution and end-user network servicing the food processing, transportation and janitorial industry. In addition, during the fiscal first quarter ended October 31, 2020, we recognized $174,000 in royalties from a nonexclusive third-party distributor.
  • Net loss for the fiscal first quarter ended October 31, 2020 was $180,000, compared to $1.1 million for the fiscal first quarter ended October 31, 2019. Net income, excluding share-based compensation, for the fiscal first quarter ended October 31, 2020 was $49,000, compared to a net loss of $667,000 for the fiscal first quarter ended October 31, 2019.
  • Net loss per share was ($0.00) for the fiscal first quarter ended October 31, 2020, compared to a net loss of ($0.01) for the fiscal first quarter ended October 31, 2019.
  • Gross margin as a percentage of net product sales was 55% and 61% for the first fiscal quarter ended October 31, 2020 and 2019, respectively. The decrease in gross margin percentage was primarily attributable to the sale of lower-margin formulations and packaging configurations of our products during the fiscal first quarter ended October 31, 2020, compared to the fiscal first quarter ended October 31, 2019.

Business Update

  • PURE® Hard Surface

    • Food Processing and Manufacturing: Our distribution network is now servicing hundreds of protein, produce, bakery and dairy facilities across the U.S. By working in tandem with our distributors, we have expanded our existing regional network addressing various food safety solutions. In addition, applications are underway addressing new opportunities in the dairy and fresh produce industry.
    • Food Transportation Sanitization: PURE’s Transport Sanitation Solution, designed to meet the FDA Food Safety Modernization Act (FSMA) requirements, added multiple food transportation companies as users, including the three major companies in the channel, for a total of six of the nation’s largest food transportation companies servicing restaurant chains, food processors and grocery store chains. This proven solution is now being adopted by processors and restaurant chains nationally.
    • Janitorial and Cleaning: Our janitorial and cleaning distributors have continued servicing numerous federal and municipal facilities, as well as school districts and universities across the country. We have made great in-roads in this channel with the help of our regional distributors as part of a national push to provide superior efficacy with an EPA-approved, no-rinse disinfectant.
    • PURE Hard Surface is now listed on the GSA AbilityOne Program, the program in which the federal government procures goods and services from companies that provide employment opportunities to individuals with disabilities. National Industries for the Blind (NIB) sponsored the inclusion of PURE Hard Surface in the program. Our partner, Lighthouse for the Blind and Visually Impaired San Francisco, is in the final stages of constructing a facility in the San Francisco Bay Area that will package PURE’s products and create jobs for the blind, thus meeting the AbilityOne Program’s requirements. Multiple government agencies, including the Federal Aviation Administration (FAA), have started purchasing PURE’s products through the AbilityOne Program.
  • PURE Control®

    • USDA-ARS (United States Department of Agriculture – Agricultural Research Service) published its research validating the work done by SmartWash Solutions® and PURE last year on efficacy on fresh-cut lettuce. An independent publication from SmartWash Solutions® stated, “This novel application and chemistry have been tested commercially and is now available to the fresh-cut market today on iceberg and romaine lettuces. This tool provides the additional incremental lethality needed to drastically reduce the potential for food-borne illness when coupled with SmartWash Solutions’® industry-leading wash system. This is a huge win for companies seeking to prevent recalls, protect their brand and assure consumer trust and safety.”
    • PURE Control is now being used to treat pre-cut lettuce, berries and tomatoes at various locations. Expansion has continued to other seasonal growing locations in the U.S. across several processors.
    • We continue to work with several processors to use PURE Control to enhance the protection of fruit, herbs, onions, broccoli and other processed vegetables.

Tom Y. Lee, Chief Executive Officer, said that, “While our fiscal Q1 results showed increased year-over-year sales growth, we did see a decrease compared to fiscal Q4 of last year. The order restocking process slowed in fiscal Q1 vs Q4 of last year due to the volume of sales recognized toward the end of fiscal Q4.

“We continue to view the commercialization of SmartWash and the progress being made by our PURE Hard Surface partners and distributors as great near-term revenue opportunities. Additionally, I’m pleased to announce another nationally-recognized quick-service restaurant has adopted our SDC technology to help mitigate food safety risks,” concluded Lee.

About PURE Bioscience, Inc.

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena. We provide solutions to combat the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain silver dihydrogen citrate, better known as SDC. This is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and mitigation of bacterial resistance. PURE is headquartered in Rancho Cucamonga, California (San Bernardino metropolitan area). Additional information on PURE is available at www.purebio.com

Forward-looking Statements: Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Statements in this press release concerning the Company’s expectations, plans, business outlook or future performance, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements.” Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; economic and other disruptions resulting from COVID-19; acceptance of the Company’s current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations and tests for PURE Control and PURE Hard Surface into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the Company’s ability to maintain relationships with its partners and other counterparties; the Company’s ability to generate sufficient revenues and reduce its operating expenses in order to reach profitability; the Company’s ability to raise the funding required to support its continued operations and the implementation of its business plan; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw meat processing and to expand its use in OLR poultry processing; competitive factors, including customer acceptance of the Company’s SDC-based products that are typically more expensive than existing treatment chemicals; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2020 and Form 10-Q for the first fiscal quarter ended October 31, 2020. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

 

PURE Bioscience, Inc.

Condensed Consolidated Balance Sheets

 

 

October 31, 2020

 

 

July 31, 2020

 

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,466,000

 

 

$

3,839,000

 

Accounts receivable

 

 

560,000

 

 

 

1,089,000

 

Inventories, net

 

 

733,000

 

 

 

547,000

 

Restricted cash

 

 

75,000

 

 

 

75,000

 

Prepaid expenses

 

 

46,000

 

 

 

16,000

 

Total current assets

 

 

4,880,000

 

 

 

5,566,000

 

Property, plant and equipment, net

 

 

465,000

 

 

 

316,000

 

Patents, net

 

 

421,000

 

 

 

441,000

 

Total assets

 

$

5,766,000

 

 

$

6,323,000

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

773,000

 

 

$

1,344,000

 

Accrued liabilities

 

 

133,000

 

 

 

168,000

 

Total current liabilities

 

 

906,000

 

 

 

1,512,000

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value: 5,000,000 shares authorized, no shares issued and outstanding

 

 

 

 

 

 

Common stock, $0.01 par value: 100,000,000 shares authorized, 87,072,951 shares issued and outstanding at October 31, 2020, and at July 31, 2020

 

 

871,000

 

 

 

871,000

 

Additional paid-in capital

 

 

127,643,000

 

 

 

127,414,000

 

Accumulated deficit

 

 

(123,654,000

)

 

 

(123,474,000

)

Total stockholders’ equity

 

 

4,860,000

 

 

 

4,811,000

 

Total liabilities and stockholders’ equity

 

$

5,766,000

 

 

$

6,323,000

 

 

PURE Bioscience, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

 

Three months ended

 

 

 

October 31,

 

 

 

2020

 

 

2019

 

Net product sales

 

$

1,417,000

 

 

$

398,000

 

Royalty revenue

 

 

174,000

 

 

 

 

Total revenue

 

 

1,591,000

 

 

 

398,000

 

Cost of goods sold

 

 

641,000

 

 

 

156,000

 

Gross Profit

 

 

950,000

 

 

 

242,000

 

Operating costs and expenses

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

1,046,000

 

 

 

1,290,000

 

Research and development

 

 

83,000

 

 

 

82,000

 

Total operating costs and expenses

 

 

1,129,000

 

 

 

1,372,000

 

Loss from operations

 

 

(179,000

)

 

 

(1,130,000

)

Other income (expense)

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(1,000

)

 

 

(2,000

)

Other income, net

 

 

 

 

 

7,000

 

Total other income (expense)

 

 

(1,000

)

 

 

5,000

 

Net loss

 

$

(180,000

)

 

$

(1,125,000

)

Basic and diluted net loss per share

 

$

(0.00

)

 

$

(0.01

)

Shares used in computing basic and diluted net loss per share

 

 

87,072,951

 

 

 

78,004,073

 

 

PURE Bioscience, Inc.

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited)

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance July 31, 2020

 

 

87,072,951

 

 

$

871,000

 

 

$

127,414,000

 

 

$

(123,474,000

)

 

$

4,811,000

 

Share-based compensation expense – stock options

 

 

 

 

 

 

 

 

208,000

 

 

 

 

 

 

208,000

 

Share-based compensation expense – restricted stock units

 

 

 

 

 

 

 

 

21,000

 

 

 

 

 

 

21,000

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(180,000

)

 

 

(180,000

)

Balance October 31, 2020 (Unaudited)

 

 

87,072,951

 

 

$

871,000

 

 

$

127,643,000

 

 

$

(123,654,000

)

 

$

4,860,000

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance July 31, 2019

 

 

76,732,334

 

 

$

768,000

 

 

$

123,900,000

 

 

$

(123,478,000

)

 

$

1,190,000

 

Issuance of common stock in private placements, net

 

 

2,862,068

 

 

 

28,000

 

 

 

802,000

 

 

 

 

 

 

830,000

 

Share-based compensation expense – stock options

 

 

 

 

 

 

 

 

268,000

 

 

 

 

 

 

268,000

 

Share-based compensation expense – restricted stock units

 

 

 

 

 

 

 

 

190,000

 

 

 

 

 

 

190,000

 

Issuance of common stock for vested restricted stock units

 

 

400,000

 

 

 

4,000

 

 

 

(4,000

)

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(1,125,000

)

 

 

(1,125,000

)

Balance October 31, 2019 (Unaudited)

 

 

79,994,402

 

 

$

800,000

 

 

$

125,156,000

 

 

$

(124,603,000

)

 

$

1,353,000

 

 

PURE Bioscience, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

Three Months Ended

 

 

 

October 31,

 

 

 

2020

 

 

2019

 

Operating activities

 

 

 

 

 

 

 

 

Net loss

 

$

(180,000

)

 

$

(1,125,000

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Share-based compensation

 

 

229,000

 

 

 

458,000

 

Amortization of stock issued for services

 

 

 

 

 

4,000

 

Depreciation and amortization

 

 

45,000

 

 

 

52,000

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

529,000

 

 

 

153,000

 

Inventories

 

 

(186,000

)

 

 

15,000

 

Prepaid expenses

 

 

(30,000

)

 

 

(16,000

)

Accounts payable and accrued liabilities

 

 

(606,000

)

 

 

139,000

 

Deferred rent

 

 

 

 

 

(4,000

)

Net cash used in operating activities

 

 

(199,000

)

 

 

(324,000

)

Investing activities

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(174,000

)

 

 

 

Net cash used in investing activities

 

 

(174,000

)

 

 

 

Financing activities

 

 

 

 

 

 

 

 

Net proceeds from the sale of common stock

 

 

 

 

 

830,000

 

Net cash provided by financing activities

 

 

 

 

 

830,000

 

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

 

(373,000

)

 

 

506,000

 

Cash, cash equivalents, and restricted cash at beginning of period

 

 

3,914,000

 

 

 

473,000

 

Cash, cash equivalents, and restricted cash at end of period

 

$

3,541,000

 

 

$

979,000

 

 

 

 

 

 

 

 

 

 

Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,466,000

 

 

$

904,000

 

Restricted cash

 

$

75,000

 

 

$

75,000

 

Total cash, cash equivalents and restricted cash

 

$

3,541,000

 

 

$

979,000

 

 

Mark Elliott, VP Finance

PURE Bioscience, Inc.

Ph: 619-596-8600 ext: 116

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Retail Technology Public Relations/Investor Relations Communications Other Consumer General Health Restaurant/Bar Agriculture Natural Resources Supermarket Other Technology Science Food/Beverage Consumer Research Health

MEDIA:

Logo
Logo

Ring Energy, Inc., Announces Results of Proxy Vote for the 2021 Board of Directors

Ring Energy, Inc., Announces Results of Proxy Vote for the 2021 Board of Directors

Company Provides Proxy Results for Seven Directors

MIDLAND, Texas–(BUSINESS WIRE)–
Ring Energy, Inc. (NYSEAM: REI) (“Ring”) (“Company”) announced today its shareholders voted decisively to approve Mr. Paul D. McKinney as Chairman of the Board of Directors as well as all six independent directors to the Board. Collectively, all seven directors were elected to serve another one-year term which will end on the date of the 2021 Annual Meeting of Stockholders, or at such time as their successors are duly elected and qualified.

Mr. Paul D. McKinney, Ring’s Chief Executive Officer and Chairman of the Board commented, “I am humbled and inspired by the trust and support Ring’s stockholders have placed in me and the independent directors that serve with me. These six directors are men and women of impeccable character and each brings unique abilities and strengths to this Board. Their prior experience and success in varying industries will lend a high degree of diversity, insight, and wisdom as we work together to enhance shareholder value.”

About Ring Energy, Inc.

Ring Energy, Inc. is an oil and gas exploration, development, and production company with current operations in Texas and New Mexico.

www.ringenergy.com

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements involve a wide variety of risks and uncertainties, and include, without limitations, statements with respect to the Company’s strategy and prospects. Such statements are subject to certain risks and uncertainties which are disclosed in the Company’s reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2019, its Form 10Q for the quarter ended September 30, 2020 and its other filings with the SEC. Readers and investors are cautioned that the Company’s actual results may differ materially from those described in the forward-looking statements due to a number of factors, including, but not limited to, the Company’s ability to acquire productive oil and/or gas properties or to successfully drill and complete oil and/or gas wells on such properties, general economic conditions both domestically and abroad, and the conduct of business by the Company, and other factors that may be more fully described in additional documents set forth by the Company.

David A. Fowler, President

Ring Energy, Inc.

(432) 682-7464

Bill Parsons

K M Financial, Inc.

(702) 489-4447

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Oil/Gas Energy

MEDIA:

Logo
Logo

Good Times Restaurants Reports Results for the Fiscal Fourth Quarter and Year Ended September 29, 2020

Good Times Restaurants Reports Results for the Fiscal Fourth Quarter and Year Ended September 29, 2020

DENVER–(BUSINESS WIRE)–Good Times Restaurants Inc. (NASDAQ: GTIM), today reported financial results for the fiscal fourth quarter and year ended September 29, 2020.

Key highlights of the Company’s financial results include:

  • Total Revenues decreased 0.9% to $28.5 million for the quarter and 0.8% to $109.9 million for the year
  • Total Restaurant Sales for Bad Daddy’s restaurants decreased 3.8% to $19.3 million for the quarter and 4.3% to $76.3 million for the year
  • Total Restaurant Sales for Good Times restaurants increased 6.3% for the quarter to $9.0 million and 9.0% to $32.8 million for the year
  • Same Store Sales for company-owned Bad Daddy’s restaurants decreased 12.2% for the quarter and decreased 17.7% for the year
  • Same Store Sales for company-owned Good Times restaurants increased 10.0% for the quarter and 7.9% for the year
  • Net Income Attributable to Common Shareholders was $1.5 million for the quarter including $0.3 million of asset impairment costs
  • For the year, Net Loss Attributable to Common Shareholders was $13.9 million including $15.6 million of asset impairment costs and $1.0 million of preopening costs
  • Adjusted EBITDA* (a non-GAAP measure) for the quarter was $2.9 million and $7.6 million for the year
  • The Company ended the quarter with $11.5 million in cash, a $5.5 million outstanding under its senior credit facility and $11.6 million outstanding in Paycheck Protection Program loans

Ryan M. Zink, the Company’s Chief Executive Officer, said, “In spite of very significant concerns about liquidity and operating cash flow at the outset of the COVID-19 pandemic, a combination of quick decision-making, teamwork, and CARES Act relief have enabled us to fight through the initial blows the pandemic hit us with, and conclude fiscal 2020 on a positive note, with improved unit economics, improved camaraderie and culture throughout the organization, and a modestly improved balance sheet compared to the end of fiscal 2019. Both of our concepts continue to outperform their respective segments within the industry, and our leadership team continues be creative and energetic, anticipating and adapting to changes in our business driven by a pandemic that will likely be with us for the foreseeable future. We are doing everything possible to ensure we continue to operate all of our restaurants safely and to the maximum extent allowed under each location’s respective regulatory guidance.”

“We expect to resume Bad Daddy’s development in the second half of fiscal 2021, developing the two remaining Bad Daddy’s leases signed in 2019 and beginning the search for our 2022 development pipeline. However, unlike our growth model in the past, we expect our future development rate to be more modest, growing primarily out of operating cash flow and at least initially, developing only a couple of restaurants per year as we make a firm commitment to financial discipline and growing from a strong balance sheet with a minimal debt load.”

Fiscal 2021 Outlook:

Due to continuing unprecedented economic conditions associated with the ongoing COVID-19 pandemic and unpredictable nature of COVID-19 and government responses to the evolving situation, the Company had previously withdrawn its prior financial outlook for fiscal 2020 and has not provided a financial outlook for 2021. In late November 2020, all twelve of the Company’s Bad Daddy’s locations in Colorado had additional restrictions imposed upon them resulting in the closure of dining rooms in those locations. The removal of those restrictions will be dictated by specific metrics related to the pandemic used by the State of Colorado in determining such restrictions. The Company is unable to reasonably predict when inside dining will again be allowed in its Colorado Bad Daddy’s restaurants. Additionally, although no other states have at this time similarly restricted inside dining where the Company has Bad Daddy’s restaurants, the possibility remains that such restrictions might be put in place with limited notice. At the current time, the Company is therefore still unable to reasonably estimate the full impact of the continuing pandemic and, beyond providing the below updates on October and November sales and a projection of Net Income and Adjusted EBITDA for the first fiscal quarter, is unable to provide a financial outlook for fiscal 2021.

The following information represents unaudited actual sales data for the first two fiscal periods of fiscal 2021:

 

 

Good Times Burgers

& Frozen Custard

 

Bad Daddy’s Burger Bar

Fiscal Period

 

Same

Store Sales1

 

Average

Weekly Sales2

 

Same

Store Sales1

 

Average

Weekly Sales2

October (4 weeks)

 

15.0%

 

25,750

 

-2.7%

 

41,782

November (4 weeks)

 

22.4%

 

27,185

 

-8.2%

 

39,903

1 Same store sales include all restaurants open at least 18 full fiscal months.

2 Average weekly sales include all company-owned restaurants.

Consolidated net income and adjusted EBITDA for the first fiscal quarter 2021 are projected to be between $0.4 million and $0.6 million, and between $1.5 million and $1.7 million, respectively. The estimate for Adjusted EBITDA includes assumptions of approximately $1.0 million of depreciation and amortization expense, $0.1 million of interest expense, $0.1 million of non-cash stock compensation expense, and ($0.1) million of non-cash rent expense, to be used in reconciling to consolidated net income.

*For a reconciliation of restaurant level operating profit and Adjusted EBITDA to the most directly comparable financial measures presented in accordance with GAAP and a discussion of why the Company considers them useful, see the financial information schedules accompanying this release.

Conference Call: Management will host a conference call to discuss its fourth quarter 2020 and fiscal year ended September 29, 2020 financial results on Tuesday, December 15, 2020 at 3:00 p.m. MT/5:00 p.m. ET. Hosting the call will be Ryan M. Zink, its Chief Executive Officer and Principal Financial Officer.

The conference call can be accessed live by dialing (888) 339-0806 and requesting the Good Times Restaurants (GTIM) call. The conference call will also be webcast live from the Company’s corporate website www.goodtimesburgers.com. An archive of the webcast will be available at the same location on the corporate website shortly after the call has concluded.

About Good Times Restaurants Inc.: Good Times Restaurants Inc. (GTIM) owns, operates, franchises and licenses 39 Bad Daddy’s Burger Bar restaurants through its wholly owned subsidiaries. Bad Daddy’s Burger Bar is a full-service “small box” restaurant concept featuring a chef-driven menu of gourmet signature burgers, chopped salads, appetizers and sandwiches with a full bar and a focus on a selection of craft microbrew beers in a high-energy atmosphere that appeals to a broad consumer base. Additionally, through its wholly-owned subsidiaries, Good Times Restaurants Inc. operates and franchises a regional quick-service restaurant chain consisting of 32 Good Times Burgers & Frozen Custard restaurants located primarily in Colorado.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of federal securities laws. The words “intend,” “may,” “believe,” “will,” “should,” “anticipate,” “expect,” “seek” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, which may cause the Company’s actual results to differ materially from results expressed or implied by the forward-looking statements. These risks include such factors as the disruption to our business from the novel coronavirus (COVID-19) pandemic and the impact of the pandemic on our results of operations, financial condition and prospects which may vary depending on the duration and extent of the pandemic and the impact of federal, state and local governmental actions and customer behavior in response to the pandemic, the lack of assurance that the full amount of the PPP loans will be forgiven, the uncertain nature of current restaurant development plans and the ability to implement those plans and integrate new restaurants, delays in developing and opening new restaurants because of weather, local permitting or other reasons, increased competition, cost increases or shortages in raw food products, and other matters discussed under the Risk Factors section of Good Times’ Annual Report on Form 10-K for the fiscal year ended September 24, 2019 filed with the SEC, and other filings with the SEC . Good Times disclaims any obligation or duty to update or modify these forward-looking statements.

Category: Financial

Good Times Restaurants Inc.

Unaudited Supplemental Information

(In thousands, except per share amounts)

 

Fiscal Quarter Ended

 

Year-To-Date

Statement of Operations

September 29,

2020

 

September 24,

2019

 

September 29,

2020

 

September 24,

2019

Net revenues:

 

 

 

 

 

 

 

Restaurant sales

$

28,297

 

 

$

28,519

 

 

$

109,078

 

 

$

109,800

 

Franchise revenues

 

208

 

 

 

254

 

 

 

780

 

 

 

955

 

Total net revenues

 

28,505

 

 

 

28,773

 

 

 

109,858

 

 

 

110,755

 

 

 

 

 

 

 

 

Restaurant operating costs:

 

 

 

 

 

 

 

Food and packaging costs

 

8,019

 

 

 

8,516

 

 

 

31,395

 

 

 

32,471

 

Payroll and other employee benefit costs

 

9,360

 

 

 

10,763

 

 

 

38,442

 

 

 

41,221

 

Restaurant occupancy costs

 

2,138

 

 

 

2,132

 

 

 

8,877

 

 

 

8,353

 

Other restaurant operating costs

 

3,678

 

 

 

3,154

 

 

 

13,351

 

 

 

11,862

 

Preopening costs

 

39

 

 

 

825

 

 

 

1,031

 

 

 

1,774

 

Depreciation and amortization

 

954

 

 

 

1,118

 

 

 

4,129

 

 

 

4,345

 

Total restaurant operating costs

 

24,188

 

 

 

26,508

 

 

 

97,225

 

 

 

100,026

 

 

 

 

 

 

 

 

General and administrative costs

 

1,562

 

 

 

2,980

 

 

 

7,100

 

 

 

9,071

 

Advertising costs

 

422

 

 

 

525

 

 

 

1,993

 

 

 

2,349

 

Franchise costs

 

6

 

 

 

7

 

 

 

20

 

 

 

38

 

Goodwill impairment charge

 

 

 

 

 

 

 

10,000

 

 

 

 

Asset impairment charge

 

315

 

 

 

2,771

 

 

 

5,606

 

 

 

2,771

 

Gain on disposal of restaurants and equipment

 

(9

)

 

 

(10

)

 

 

(45

)

 

 

(5

)

Income (loss) from operations

 

2,021

 

 

 

(4,008

)

 

 

(12,041

)

 

 

(3,495

)

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

Interest income (expense), net

 

(115

)

 

 

(192

)

 

 

(753

)

 

 

(753

)

Other income (expense)

 

0

 

 

 

1

 

 

 

 

 

 

 

Total other expense

 

(115

)

 

 

(191

)

 

 

(753

)

 

 

(753

)

Net income (loss)

 

1,906

 

 

 

(4,199

)

 

 

(12,794

)

 

 

(4,248

)

Loss (income) attributable to non-controlling interests

 

(384

)

 

 

23

 

 

 

(1,122

)

 

 

(889

)

Net Income (loss) attributable to common shareholders

$

1,522

 

 

$

(4,176

)

 

$

(13,916

)

 

$

(5,137

)

 

 

 

 

 

 

 

Basic and diluted income (loss) per share

$

0.12

 

 

$

(0.33

)

 

$

(1.10

)

 

$

(0.41

)

 

 

 

 

 

 

 

Basic and diluted weighted average common shares outstanding

 

12,601

 

12,540

 

 

 

12,595

 

 

 

12,523

Good Times Restaurants Inc.

Unaudited Supplemental Information

(In thousands)

Balance Sheet Data

 

September 29, 2020

 

September 24, 2019

Cash and cash equivalents

 

$

11,454

 

$

2,745

 

 

 

 

 

Current assets

 

 

13,491

 

 

4,915

 

 

 

 

 

Total assets1

 

$

99,693

 

$

59,905

 

 

 

 

 

Current maturities of long-term debt

 

$

6,242

 

$

 

 

 

 

 

Long-term debt due after one year

 

 

10,903

 

 

12,850

 

 

 

 

 

Stockholders’ equity

 

$

14,983

 

$

28,920

1 Includes approximately $49.3 million of operating lease right of use assets recorded during 2020 as a result of the adoption of Accounting Standards Update 2016-02, Leases (Topic 842).

Supplemental Information (dollars in thousands):

 

Bad Daddy’s Burger Bar

 

Good Times Burgers &

Frozen Custard

 

————————– Fiscal Fourth Quarter—————————

 

 

2020

 

 

2019

 

 

2020

 

 

2019

Restaurant sales

$

19,287

 

$

20,039

 

$

9,010

 

$

8,480

Restaurants opened during period

 

 

 

2

 

 

 

 

Restaurants closed during period

 

 

 

 

 

 

 

Restaurants open at period end

 

37

 

 

35

 

 

25

 

 

26

 

 

 

 

 

 

 

 

Restaurant operating weeks

 

481

 

 

432

 

 

325

 

 

338

 

 

 

 

 

 

 

 

Average weekly sales per restaurant

$

40.1

 

$

46.4

 

$

27.7

 

$

25.1

 

Bad Daddy’s Burger Bar

 

Good Times Burgers &

Frozen Custard

 

———————————Fiscal Year————————————

 

 

2020

 

 

2019

 

 

2020

 

 

2019

Restaurant sales

$

76,315

 

$

79,753

 

$

32,763

 

$

30,047

Restaurants opened during period

 

2

 

 

4

 

 

 

 

Restaurants closed during period

 

 

 

 

 

1

 

 

Restaurants open at period end

 

37

 

 

35

 

 

25

 

 

26

 

 

 

 

 

 

 

 

Restaurant operating weeks

 

1,952

 

 

1,699

 

 

1,339

 

 

1,352

 

 

 

 

 

 

 

 

Average weekly sales per restaurant

$

39.1

 

$

46.9

 

$

24.5

 

$

22.2

Reconciliation of Non-GAAP Measurements to U.S. GAAP Results

Reconciliation of Non-GAAP Restaurant-Level Operating Profit to Income (Loss) from Operations

(In thousands, except percentage data)

 

Bad Daddy’s Burger Bar

 

Good Times Burgers & Frozen Custard

 

Good Times

Restaurants Inc.

 

————————————————————————— Fiscal Quarter Ended———————————————————————————–

 

September 29,

2020

 

September 24,

2019

 

September 29,

2020

 

September 24,

2019

 

Sept 29,

2020

 

Sept 24,

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restaurant sales

$

19,287

100.0

%

 

$

20,040

100.0

%

 

$

9,010

100.0

%

 

$

8,480

100.0

%

 

$

28,297

 

 

$

28,520

 

Restaurant operating costs (exclusive of depreciation and

amortization shown separately

below):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Food and packaging costs

 

5,215

27.0

%

 

 

5,869

29.3

%

 

 

2,805

31.1

%

 

 

2,647

31.2

%

 

 

8,020

 

 

 

8,516

 

Payroll and benefits costs

 

6,491

33.7

%

 

 

7,721

38.5

%

 

 

2,868

31.8

%

 

 

3,042

35.9

%

 

 

9,359

 

 

 

10,763

 

Restaurant occupancy costs

 

1,424

7.4

%

 

 

1,391

6.9

%

 

 

713

7.9

%

 

 

742

8.7

%

 

 

2,137

 

 

 

2,133

 

Other restaurant operating costs

 

2,860

14.8

%

 

 

2,391

11.9

%

 

 

819

9.1

%

 

 

763

9.0

%

 

 

3,679

 

 

 

3,154

 

Restaurant-level operating profit

$

3,297

17.1

%

 

$

2,668

13.3

%

 

$

1,805

20.0

%

 

$

1,286

15.2

%

 

$

5,102

 

 

$

3,954

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Franchise royalty income, net

 

 

 

 

 

 

 

 

 

 

 

 

 

208

 

 

 

254

 

Deduct – Other operating:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

954

 

 

 

1,118

 

General and administrative

 

 

 

 

 

 

 

 

 

 

 

 

 

1,562

 

 

 

2,980

 

Advertising costs

 

 

 

 

 

 

 

 

 

 

 

 

 

422

 

 

 

525

 

Franchise costs

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

7

 

Gain on restaurant asset sale

 

 

 

 

 

 

 

 

 

 

 

 

 

(9

)

 

 

(10

)

Impairment of long-lived assets

 

 

 

 

 

 

 

 

 

 

 

 

 

315

 

 

 

2,771

 

Pre-opening costs

 

 

 

 

 

 

 

 

 

 

 

 

 

39

 

 

 

825

 

Total other operating

 

 

 

 

 

 

 

 

 

 

 

 

 

3,289

 

 

 

8,216

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

 

 

 

 

 

 

 

 

 

 

 

$

2,021

 

 

$

(4,008

)

Certain percentage amounts in the table above do not total due to rounding as well as the fact that restaurant operating costs are expressed as a percentage of restaurant revenues (as opposed to total revenues).

Reconciliation of Non-GAAP Measurements to U.S. GAAP Results

Reconciliation of Non-GAAP Restaurant-Level Operating Profit to Income (Loss) from Operations

(In thousands, except percentage data)

 

Bad Daddy’s Burger Bar

 

Good Times Burgers & Frozen Custard

 

Good Times

Restaurants Inc.

 

———————————————————————————————- Year to Date—————————————————————————————————-

 

September 29,

2020

 

September 24,

2019

 

September 29,

2020

 

September 24,

2019

 

Sept 29,

2020

 

Sept 24,

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restaurant sales

$

76,315

100.0

%

 

$

79,753

100.0

%

 

$

32,763

100.0

%

 

$

30,047

100.0

%

 

$

109,078

 

 

$

109,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restaurant operating costs (exclusive of

depreciation and amortization shown

separately below):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Food and packaging costs

 

21,323

27.9

%

 

 

23,006

28.8

%

 

 

10,072

30.7

%

 

 

9,465

31.5

%

 

 

31,395

 

 

 

32,471

 

Payroll and other employee benefit

costs

 

27,465

36.0

%

 

 

30,224

37.9

%

 

 

10,977

33.5

%

 

 

10,997

36.6

%

 

 

38,442

 

 

 

41,221

 

Restaurant occupancy costs

 

6,025

7.9

%

 

 

5,413

6.8

%

 

 

2,852

8.7

%

 

 

2,940

9.8

%

 

 

8,877

 

 

 

8,353

 

Other restaurant operating costs

 

10,409

13.6

%

 

 

9,161

11.5

%

 

 

2,942

9.0

%

 

 

2,701

9.0

%

 

 

13,351

 

 

 

11,862

 

Restaurant-level operating profit

$

11,093

14.5

%

 

$

11,949

15.0

%

 

$

5,920

18.1

%

 

$

3,944

13.1

%

 

$

17,013

 

 

$

15,893

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Franchise royalty income, net

 

 

 

 

 

 

 

 

 

 

 

 

 

780

 

 

 

955

 

Deduct – Other operating:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

4,129

 

 

 

4,345

 

General and administrative

 

 

 

 

 

 

 

 

 

 

 

 

 

7,100

 

 

 

9,071

 

Advertising costs

 

 

 

 

 

 

 

 

 

 

 

 

 

1,993

 

 

 

2,349

 

Franchise costs

 

 

 

 

 

 

 

 

 

 

 

 

 

20

 

 

 

38

 

Gain on restaurant asset sale

 

 

 

 

 

 

 

 

 

 

 

 

 

(45

)

 

 

(5

)

Impairment of goodwill

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000

 

 

 

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

 

 

 

 

 

5,606

 

 

 

2,771

 

Pre-opening costs

 

 

 

 

 

 

 

 

 

 

 

 

 

1,031

 

 

 

1,774

 

Total other operating

 

 

 

 

 

 

 

 

 

 

 

 

 

29,834

 

 

 

20,343

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

 

 

 

 

 

 

 

 

 

 

$

(12,041

)

 

$

(3,495

)

Certain percentage amounts in the table above do not total due to rounding as well as the fact that restaurant operating costs are expressed as a percentage of restaurant revenues (as opposed to total revenues).

The Company believes that restaurant-level operating profit is an important measure for management and investors because it is widely regarded in the restaurant industry as a useful metric by which to evaluate restaurant-level operating efficiency and performance. The Company defines restaurant-level operating profit to be restaurant revenues minus restaurant-level operating costs, excluding restaurant closures and impairment costs. The measure includes restaurant-level occupancy costs, which includes fixed rents, percentage rents, common area maintenance charges, real estate and personal property taxes, general liability insurance and other property costs, but excludes depreciation. The measure excludes depreciation and amortization expense, substantially all of which is related to restaurant level assets, because such expenses represent historical sunk costs which do not reflect current cash outlay for the restaurants. The measure also excludes selling, general and administrative costs, and therefore excludes occupancy costs associated with selling, general and administrative functions, and pre-opening costs. The Company excludes restaurant closure costs as they do not represent a component of the efficiency of continuing operations. Restaurant impairment costs are excluded, because similar to depreciation and amortization, they represent a non-cash charge for the Company’s investment in its restaurants and not a component of the efficiency of restaurant operations. Restaurant-level operating profit is not a measurement determined in accordance with generally accepted accounting principles (“GAAP”) and should not be considered in isolation, or as an alternative, to income from operations or net income as indicators of financial performance. Restaurant-level operating profit as presented may not be comparable to other similarly titled measures of other companies. The tables above set forth certain unaudited information for the current and prior year fiscal quarters and year-to-date periods for fiscal 2020 and fiscal 2019, expressed as a percentage of total revenues, except for the components of restaurant operating costs, which are expressed as a percentage of restaurant revenues.

Reconciliation of Net Income (Loss) to Non-GAAP Adjusted EBITDA (Thousands of US Dollars)

 

Fiscal Quarter Ended

 

Year-to-Date

 

Sept 29,

2020

 

Sept 24,

2019

 

Sept 29,

2020

 

Sept 24,

2019

Adjusted EBITDA:

 

 

 

 

 

 

 

Net income (loss), as reported

$

1,522

 

 

$

(4,176

)

 

$

(13,916

)

 

$

(5,137

)

Depreciation and amortization 1

 

942

 

 

 

1,105

 

 

 

4,082

 

 

 

4,262

 

Interest expense, net

 

115

 

 

 

191

 

 

 

753

 

 

 

753

 

EBITDA

 

2,579

 

 

 

(2,880

)

 

 

(9,081

)

 

 

(122

)

Pre-opening expense 1

 

40

 

 

 

824

 

 

 

1,032

 

 

 

1,752

 

Non-cash stock-based compensation

 

60

 

 

 

388

 

 

 

283

 

 

 

719

 

Non-recurring severance costs

 

 

 

 

731

 

 

 

 

 

 

731

 

GAAP rent-cash rent difference

 

(88

)

 

 

(61

)

 

 

(207

)

 

 

(111

)

Gain on disposal of assets

 

(9

)

 

 

(9

)

 

 

(45

)

 

 

(5

)

Goodwill impairment charge

 

 

 

 

 

 

 

10,000

 

 

 

 

Asset impairment charge 1

 

315

 

 

 

2,476

 

 

 

5,606

 

 

 

2,476

 

Adjusted EBITDA

$

2,897

 

 

$

1,469

 

 

$

7,588

 

 

$

5,440

 

Adjusted EBITDA is a supplemental measure of operating performance that does not represent and should not be considered as an alternative to net income or cash flow from operations, as determined by GAAP, and our calculation thereof may not be comparable to that reported by other companies. This measure is presented because we believe that investors’ understanding of our performance is enhanced by including this non-GAAP financial measure as a reasonable basis for evaluating our ongoing results of operations.

Adjusted EBITDA is calculated as net income (loss) before interest expense, provision for income taxes and depreciation and amortization and further adjustments to reflect the additions and eliminations presented in the table above.

Adjusted EBITDA is presented because: (i) we believe it is a useful measure for investors to assess the operating performance of our business without the effect of non-cash charges such as depreciation and amortization expenses and asset disposals, closure costs and restaurant impairments, and (ii) we use adjusted EBITDA internally as a benchmark for certain of our cash incentive plans and to evaluate our operating performance or compare our performance to that of our competitors. The use of adjusted EBITDA as a performance measure permits a comparative assessment of our operating performance relative to our performance based on our GAAP results, while isolating the effects of some items that vary from period to period without any correlation to core operating performance or that vary widely among similar companies. Companies within our industry exhibit significant variations with respect to capital structures and cost of capital (which affect interest expense and income tax rates) and differences in book depreciation of property, plant and equipment (which affect relative depreciation expense), including significant differences in the depreciable lives of similar assets among various companies. Our management believes that adjusted EBITDA facilitates company-to-company comparisons within our industry by eliminating some of these foregoing variations. Adjusted EBITDA, as presented, may not be comparable to other similarly-titled measures of other companies, and our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by excluded or unusual items.

______________________________________________________

1 Depreciation and amortization, preopening expense, and asset impairment charge have been reduced by any amounts attributable to non-controlling interests.

Ryan M. Zink, President and Chief Executive Officer (303) 384-1432

Christi Pennington (303) 384-1440

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Retail Restaurant/Bar Food/Beverage

MEDIA:

Logo
Logo

Mondelēz International Appoints Laura Stein as EVP, General Counsel, Corporate & Legal Affairs

  • Stein to succeed Gerd Pleuhs who will retire after more than 35 years with the Company

CHICAGO, Dec. 15, 2020 (GLOBE NEWSWIRE) — Mondelēz International (NASDAQ: MDLZ) today announced that Laura Stein will become EVP, General Counsel, Corporate & Legal Affairs, effective January 11.

Stein will be responsible for the oversight of the company’s global legal, compliance, corporate reputation and ESG agendas, including public and government affairs, internal and external corporate communications, sustainability, community and foundation efforts. She will report directly to Dirk Van de Put, Chairman and Chief Executive Officer, and will be a member of the Mondelēz International Leadership Team. Stein will replace Gerd Pleuhs, who will retire at the end of April following a transition period, and after more than 35 years with the company.

“With decades of experience promoting and protecting people, brand and corporate reputations around the globe, Laura is the perfect leader to continue guiding our Corporate & Legal Affairs function into the future, said Dirk Van de Put, Chairman & CEO of Mondelēz International. “I am looking forward to Laura’s leadership and partnership in ensuring we as a company are purpose led and values enabled.”

Van de Put continued, “I would like to thank Gerd for his significant contributions to our company over many decades. Gerd has been a vital member of my leadership team and has built a world-class global Corporate & Legal Affairs department that is well positioned to support our long-term growth strategy.”

Stein brings 20 years of public company experience to the role. She joins Mondelēz International from The Clorox Company, a global CPG leader with iconic brands sold in more than 100 countries, where she served as EVP, General Counsel & Corporate Affairs. Since 2005, Laura has successfully led Clorox’s global Legal and Corporate Affairs functions, including compliance, enterprise risk, audit, communications, government affairs, ESG and community affairs. Passionate about community volunteering, pro bono service and diversity and inclusion, she has served as President of The Clorox Company Foundation and sponsored the Clorox Women’s Employee Resource Group. Prior to her time at Clorox, Laura served as SVP, General Counsel at the H.J. Heinz Company, leading a legal department with colleagues across Europe, Asia and Latin America.

“From the company’s iconic brands and unique global footprint to their impactful sustainability and growth strategy, there are many reasons why I am thrilled to join Mondelēz International,” said Laura Stein. “I look forward to working with Dirk and his leadership team, alongside the talented Corporate and Legal affairs teams around the world, to help realize the company’s mission to lead the future of snacking.”

Stein currently is a director of Franklin Resources Inc. (a global investment organization known as Franklin Templeton Investments) and Canadian National Railway Company (CN, a North American transportation company). She is co-chair of the Corporate Pro Bono Advisory Board and is on the board of the Leadership Council on Legal Diversity, the Pro Bono Institute, the Harvard Law School Program on the Future of the Legal Profession and the CEELI Institute. Stein received her J.D. from Harvard Law School and is a graduate of Dartmouth College, where she earned undergraduate and master’s degrees.

About Mondelēz International
Mondelēz International, Inc. (NASDAQ: MDLZ) empowers people to snack right in over 150 countries around the world. With 2019 net revenues of approximately $26 billion, MDLZ is leading the future of snacking with iconic global and local brands such as OREO, belVita and LU biscuits; Cadbury Dairy Milk, Milka and Toblerone chocolate; Sour Patch Kids candy and Trident gum. Mondelēz International is a proud member of the Standard and Poor’s 500, Nasdaq 100 and Dow Jones Sustainability Index. Visit www.mondelezinternational.com or follow the company on Twitter at www.twitter.com/MDLZ.

Contact: Tom Armitage (Media)  
  +1 847 943 5678  
  [email protected]  



4D Molecular Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

EMERYVILLE, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (4DMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced today the closing of its initial public offering of 9,660,000 shares of its common stock, including 1,260,000 shares sold pursuant to the full exercise of the underwriters’ option to purchase additional shares, at a price of $23.00 per share. The aggregate gross proceeds of the offering were approximately $222 million, before deducting underwriting discounts and commissions and other offering expenses. The shares began trading on the Nasdaq Global Select Market on December 11, 2020 under the ticker symbol “FDMT.”

Goldman Sachs & Co. LLC, BofA Securities and Evercore ISI acted as book-running managers for the offering.

Registration statements relating to these securities have been filed with the Securities and Exchange Commission (SEC) and became effective on December 10, 2020. Copies of the registration statements can be accessed through the SEC’s website at www.sec.gov. This offering was made only by means of a prospectus. A copy of the final prospectus relating to this offering may be obtained from: Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, or by email at [email protected]; BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, North Carolina 28255-001, or by email at [email protected]; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 36th Floor, New York, New York 10055, by telephone at (888) 474-0200, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About 4DMT

4DMT is a clinical-stage gene therapy company pioneering the development of product candidates using targeted and evolved AAV vectors. 4DMT seeks to unlock the full potential of gene therapy using its platform, Therapeutic Vector Evolution, which combines the power of directed evolution with approximately one billion synthetic capsid sequences to invent evolved vectors for use in targeted gene therapy products. The company is initially focused in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The 4DMT targeted and evolved vectors are invented with the goal of being delivered through clinically routine, well-tolerated and minimally invasive routes of administration, transducing diseased cells in target tissues efficiently, having reduced immunogenicity and, where relevant, having resistance to pre-existing antibodies. 4DMT is currently conducting three clinical trials: 4D-125 is in a Phase 1/2 clinical trial for XLRP, 4D-110 is in a Phase 1 clinical trial for choroideremia and 4D-310 is in a Phase 1/2 clinical trial for Fabry disease.

4D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT.

Contacts:

Media:

Theresa Janke
[email protected]

Investors:

Mike Zanoni
Endurance Advisors
[email protected]



Leslie’s, Inc. to Report Fourth Quarter and Full Fiscal 2020 Financial Results on December 21, 2020

PHOENIX, Dec. 15, 2020 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s” or “Company”; NASDAQ:LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, today announced that its financial results for the fourth quarter and full fiscal 2020 will be released before market open on Monday, December 21, 2020. The Company will host a conference call at 9:00 a.m. Eastern Time to discuss the financial results.

Investors and analysts interested in participating in the call are invited to dial 877-407-0784 (international callers please dial 1-201-689-8560) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at https://ir.lesliespool.com/.

A recorded replay of the conference call will be available within approximately three hours of the conclusion of the call and can be accessed online at https://ir.lesliespool.com/ for 90 days.

About Leslie’s

Founded in 1963, Leslie’s is the largest direct-to-consumer brand in the U.S. pool and spa care industry, serving residential, professional, and commercial consumers. Leslie’s markets its products through more than 900 physical locations and multiple digital platforms. The company employs more than 5,000 associates, pool and spa care experts, and certified technicians who are passionate about empowering consumers with the knowledge, products, and solutions necessary to confidently maintain and enjoy their pools and spas.

Contact

Investors

Farah Soi/Caitlin Churchill
ICR
[email protected]



Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and development experience in academic, government, in vitro diagnostic and device industry settings.

Dr. Stankovic is currently managing partner at Koliada Consulting, LLC, a firm focused on biotech, medical devices and in vitro diagnostics. Previously, she was Senior Vice President, World Wide Regional Medical Affairs and Global Health, for Becton, Dickinson and Company (BD). Dr. Stankovic served in senior roles at BD for more than a decade, leading medical affairs and clinical operations for various BD business units.

Prior to her career at BD, she was Associate Clinical Professor, Department of Pathology, Microbiology and Immunology, at Vanderbilt University School of Medicine. She also served for two years as a Guest Lecturer in the Department of Pathology at Harvard Medical School. Dr. Stankovic is a former Chief Resident in the Department of Pathology at the University of Alabama at Birmingham. She is a boardcertified clinical pathologist with subspecialty training in blood bank/transfusion medicine and hematopathology.

“I am honored to join the Fluidigm team at this exciting time when the company’s leadership in infectious disease testing and immune profiling has enabled it to play a major role in addressing the COVID-19 pandemic,” said Dr. Stankovic. “Fluidigm is positioned to make meaningful contributions to life science research for the long term, and I am delighted for the opportunity to be a part of that journey.”

Dr. Stankovic possesses significant public health experience. She is a former official of the Centers for Disease Control and Prevention, having served as Medical Officer, Public Health Practice Program Office, Division of Laboratory Systems. Her career also includes medical oversight and compliance posts at Quest Diagnostics, Immucor, Inc., and the American Red Cross. 

“Dr. Stankovic’s medical and public health expertise, coupled with remarkably broad experience across clinical and scientific institutions, makes her ideally suited to help us chart Fluidigm’s course in 2021 and beyond,” said Chris Linthwaite, President and CEO. “Her counsel will be particularly valuable as we execute further our diagnostics roadmap, expand the role of our technology in cuttingedge immunology research and clinical trials, and engage more directly with government and public health agencies.

“Dr. Stankovic is a critical and welcome addition to our board at this historic time for Fluidigm.”

Dr. Stankovic earned her MD at The University of Belgrade, where she also obtained a PhD in Immunology. She holds a Master of Science in Public Health, Health Policy and Outcomes Research from the University of Alabama at Birmingham.

About Fluidigm

Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. For more information, visit fluidigm.com.

Fluidigm, the Fluidigm logo, and CyTOF are trademarks and/or registered trademarks of Fluidigm Corporation in the United States and/or other countries. All other trademarks are the sole property of their respective owners.

Available Information

We use our website (fluidigm.com), investor site (investors.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm), and LinkedIn page (linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts.


Fluidigm

Media:
Mark Spearman
Senior Director, Corporate Communications
650 243 6621

[email protected]

Investors:
Agnes Lee
Vice President, Investor Relations
650 416 7423

[email protected]